Top compounds associated with response to AC104534.3


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.17 2e-06
mRNA clofarabine CTRPv2 pan-cancer AAC 0.14 4e-06
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.15 9e-06
mRNA Cytarabine CTRPv2 pan-cancer AAC 0.13 2e-05
mRNA decitabine:carboplatin (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.13 3e-05
mRNA dinaciclib CTRPv2 pan-cancer AAC 0.21 4e-05
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.14 4e-05
mRNA tivantinib CTRPv2 pan-cancer AAC 0.2 5e-05
mRNA SB-743921 CTRPv2 pan-cancer AAC 0.14 5e-05
mRNA COL-3 CTRPv2 pan-cancer AAC 0.16 6e-05
Download CSV